Hematology
Raymond Alexanian, M.D.
Professor Emeritus of Medicine
Houston, TX
Dr. Alexanian is a pioneering figure in multiple myeloma research who spent nearly five decades at MD Anderson Cancer Center. He developed the MP (melphalan-prednisone) regimen that became the standard of care for myeloma and co-developed the VAD regimen with Bart Barlogie. He received the Waldenstrom Award in 2001 for his contributions.
Credentials
Board Certifications
- Internal Medicine
- Hematology
Education & Training
- MD, Harvard Medical School
- BA, Dartmouth College
- Internal Medicine Residency, University of Washington School of Medicine, Seattle
- Hematology Training, Christie Hospital, Manchester, UK
Peer Recognition
- Healthgrades — Healthgrades Honor Roll
Recognition & Leadership
Leadership Roles
- Chief of Section, Myeloma, MD Anderson Cancer Center (1998-2004)
Clinical Focus
Subspecialties
Multiple Myeloma
Conditions & Treatments
Hematologic MalignanciesMultiple Myeloma
Practice Details
Hospital Affiliations
- University of Texas MD Anderson Cancer Center